DOI: 10.1006/cimm.2000.1689

Paper Summary:

Title: Adjuvant Activities of Immune Response Modifier R-848: Comparison with CpG ODN

Author(s): John P. Vasilakos; Rose M.A. Smith; Sheila J. Gibson; Jana M. Lindh; Linda K. Pederson; Michael J. Reiter; Michael H. Smith; Mark A. Tomai

Year: 2000

DOI: 10.1006/cimm.2000.1689

URL: https://doi.org/10.1006/cimm.2000.1689

Download Paper

Received on: 2025-02-11

✍: FYIcenter.com

2025-03-12, ∼563👍, 0💬

DOI: 10.1016/S0142-9612(97)00227-5
Paper Summary: Title: Preparation of hydrogel microspheres by coacervation of aqueous polyphosphazene solutions Author(s): Alexander K. Andrianov; Jianping Chen; Lendon G. Payne Year: 1998 DOI: 10.1016/S0142-9612(97)00227-5 Received on: 2025-02-11 2025-03-12, ∼588🔥, 0💬

DOI: 10.1016/j.jim.2005.07.014
Paper Summary: Title: Monitoring of cellular responses after vaccination against tetanus toxoid: Comparison of the measurement of IFN-γ production by ELISA, ELISPOT, flow cytometry and real-time PCR Author(s): Joël Tassignon; Wivine Burny; Samira Dahmani; Lin Zhou; Patrick Stordeur; Baudouin Byl; Do... 2025-03-12, ∼577🔥, 0💬

DOI: 10.1006/cimm.2000.1689
Paper Summary: Title: Adjuvant Activities of Immune Response Modifier R-848: Comparison with CpG ODN Author(s): John P. Vasilakos; Rose M.A. Smith; Sheila J. Gibson; Jana M. Lindh; Linda K. Pederson; Michael J. Reiter; Michael H. Smith; Mark A. Tomai Year: 2000 DOI: 10.1006/cimm.2000.1689 Received o... 2025-03-12, ∼564🔥, 0💬

DOI: 10.1016/S0264-410X(00)00499-0
Paper Summary: Title: The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine Author(s): Audino Podda Year: 2001 DOI: 10.1016/S0264-410X(00)00499-0 Received on: 2025-02-11 2025-03-12, ∼559🔥, 0💬

DOI: 10.1016/S0960-894X(99)00374-1
Paper Summary: Title: Synthesis and biological evaluation of a new class of vaccine adjuvants: aminoalkyl glucosaminide 4-phosphates (AGPs) Author(s): David A. Johnson; C. Gregory Sowell; Craig L. Johnson; Mark T. Livesay; David S. Keegan; Michael J. Rhodes; J. Terry Ulrich; Jon R. Ward; John L. Can... 2025-03-12, ∼555🔥, 0💬

DOI: 10.1046/j.1365-2230.2002.01151.x
Paper Summary: Title: Imiquimod and the imidazoquinolones: mechanism of action and therapeutic potential Author(s): M. A. Stanley Year: 2002 DOI: 10.1046/j.1365-2230.2002.01151 .xReceived on: 2025-02-11 2025-03-12, ∼549🔥, 0💬

DOI: 10.1586/14760584.2.2.219
Paper Summary: Title: Enhancement of antigen-specific immunity via the TLR4 ligands MPL™ adjuvant and Ribi.529 Author(s): Evans, Jay T; Cluff, Christopher W; Johnson, David A; Lacy, Michael J; Persing, David H; Baldridge, Jory R Year: 2003 DOI: 10.1586/14760584.2.2.219 Received on: 2025-02-11 2025-03-12, ∼543🔥, 0💬

DOI: 10.1586/14760584.2.2.197
Paper Summary: Title: MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profile Author(s): Podda, Audino; Del Giudice, Giuseppe Year: 2003 DOI: 10.1586/14760584.2.2.197 Received on: 2025-02-11 2025-03-12, ∼537🔥, 0💬

DOI: 10.1016/j.antiviral.2004.07.002
Paper Summary: Title: Resiquimod: a new immune response modifier with potential as a vaccine adjuvant for Th1 immune responses Author(s): Jashin J. Wu; David B. Huang; Stephen K. Tyring Year: 2004 DOI: 10.1016/j.antiviral.2004.07.00 2Received on: 2025-02-11 2025-03-12, ∼531🔥, 0💬